A Clinicopathologic Study of 100 Cases of Parkinson's Disease

Archives of Neurology

Volumn 50, Issue 2, 1993, Pages 140-148

  Hughes, Andrew J ^a   Lees, Andrew J ^a   Daniel, Susan E ^b   Blankson, Siobhan ^b  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b Institute of Neurology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL FEATURE; CONFUSION; DEMENTIA; DISEASE DURATION; DYSKINESIA; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TREMOR;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; FEMALE; HUMAN; LEVODOPA; LEWY BODIES; MALE; MIDDLE AGE; MOVEMENT DISORDERS; NERVOUS SYSTEM DISEASES; PARKINSON DISEASE; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS;

EID: 0027465936     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1993.00540020018011     Document Type: Article

References (46)

1. Parkinson J. An Essay on the Shaking Palsy. London, England: Sherwood, Nelly and Jones; 1817.
2. Hughes AJ, Daniel SE, Kilford L, Lees AJ. The accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study. J Neurol Neurosurg Psychiatry. 1992;55:181-184.
3. Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin RC. Clinically atypical expression of pathologically typical Lewy body parkinsonism. Clin Neuropharmacol. 1990;13:36-47.
4. Oppenheimer DR. Diseases of the basal ganglia, cerebellum and motor neurons. In: Adams JH, Corsellis JAN, Duchen LW, eds. Greenfield's Neuropathology. 4th ed. New York, NY: John Wiley & Sons Inc; 1984:699-747.
5. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 1967;17:427-442.
6. Folstein MF, Folstein SE. ‘Mini-Mental State’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
7. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988; 51:745-752.
8. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985;42:1097-1105.
9. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol. 1990;237: 197-204.
10. Gibb WRG, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol. 1989; 15:27-44.
11. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndrome of parkinsonism and Huntington: clinical, morphological and neurochemical correlations. J Neurol Sci. 1973;20:415-455.
12. Mutch WJ, Dingwall-Fordyce I, Downie AW, Patterson JG, Roy SK. Parkinson's disease in a Scottish city. BMJ. 1986;292:534-536.
13. Zetusky WJ, Jankovic L, Pirozzolo FJ. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology. 1985;35:522-526.
14. Caraceni T, Giulio S, Massimo M. The occurrence of motor fluctuations in parkinsonian patients treated with long-term levodopa: role of early treatment and disease progression. Neurology. 1991;41:380-384.
15. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Meunter MD. Multi-center study of Parkinson mortality with early versus late dopa treatment. Ann Neurol. 1987;22:8-12.
16. Martilla RJ, Rinne UK. Dementia in Parkinson's disease. Acta Neurol Scand. 1976;54:431-441.
17. Kurtzke JF, Murphy FM. The changing patterns of death rates in parkinsonism. Neurology. 1990;40:42-49.
18. Strang RR. The occurrence of peptic ulceration in patients with parkinsonism. Acta Neurol Scand. 1966;42:124.
19. Jansson B, Jankovic J. Low cancer rates among patients with Parkinson's disease. Ann Neurol. 1985;17:505.
20. Diamond SG, Markham CH, Hoehn MM, McDowell FH, Meunter MD. An examination of male-female differences in progression and mortality of Parkinson's disease. Neurology. 1990;40:763-766.
21. Quinn NP, Rossor MN, Marsden CD. Dementia and Parkinson's disease: pathological and neurochemical considerations. Br Med Bull. 1986; 42:86-90.
22. Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young and old-onset Parkinson's disease. Neurology. 1988;38:1402-1406.
23. Martilla RJ, Rinne UK. Epidemiology of Parkinson's disease: An overview. J Neural Transm. 1981;51:135-148.
24. Brown RG, Marsden CD. How common is dementia in Parkinson's disease? Lancet. 1984;2:1262-1265.
25. Gibb WRG. Dementia and Parkinson's disease. Br J Psychiatry. 1989; 154:596-614.
26. Lees AJ. Parkinson's disease and dementia. Lancet. 1985;1:43-44.
27. Hoehn MM. Parkinsonism treated with levodopa, progression and mortality. J Neural Transm Suppl. 1983;19:253-264.
28. Markham CH, Diamond SG. Long-term follow-up of early dopa treatment in Parkinson's disease. Ann Neurol. 1986;19:365-372.
29. Cedarbaum JM, Gandy SE, McDowell FH. 'Early' initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease. Neurology. 1991;41:622-629.
30. Rivest J, Quinn N, Marsden CD. Dystonia in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Neurology. 1990;40:1571-1578.
31. Joachim CL, Morris JH, Selkkoe DJ. Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases. Ann Neurol. 1988;24:50-56.
32. Jellinger K. New developments in the pathology of Parkinson's disease. Adv Neurol. 1990;53:1-16.
33. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology. 1987;37:754-760.
34. Woodard JS. Concentric hyaline inclusion body formation in mental disease: Analysis of 27 cases. J Neuropathol Exp Neurol. 1962;21:442-449.
35. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: A clinical and pathological entity. Neurology. 1990;40:1-8.
36. Daniel SE, Lees AJ. Neuropathological features of Alzheimer's disease in nondemented parkinsonian patients. J Neurol Neurosurg Psychiatry. 1991;54:972-975.
37. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry. 1989;52:1236-1247.
38. Kuljis RO, Martin-Vasallo P, Peress NS. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neurosci Lett. 1989;106:49-54.
39. Xuereb JH, Tomlinson BE, Irving D, Perry RH, Blessed G, Perry EK. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. Adv Neurol. 1990;53:35-40.
40. Perry RH, Irving D, Blessed G, Perry EK, Fairbairn AF. Clinically and neuropathologically distinct form of dementia in the elderly. Lancet. 1989; 1:166.
41. Morris JC, Drazner M, Fulling K, Grant EA, Goldring J. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. Arch Neurol. 1989;46:651-657.
42. Mosla PK, Martila RJ, Rinne UK. Extrapyramidal signs in Alzheimer's disease. Neurology. 1984;34:1114-1116.
43. Gibb WRG. Cortical Lewy body dementia. Behav Neurol. 1990;3: 189-196.
44. Brack H, Brack E. Cognitive impairment in Parkinson's disease: Amyloid plaques, neurofibrillary tangles and neuropil threads in the cerebral cortex. J Neural Transm. 1990;2:45-57.
45. Knopman DS, Mastri AR, Frey WH, Sung JH, Rustan T. Dementia lacking distinctive histologic features: A common non-Alzheimer degenerative dementia. Neurology. 1990;40:251-256.
46. Alvord EC Jr, Forno LS, Kusska JA, Kauffman RJ, Rhodes JS, Goetowski CR. The pathology of parkinsonism: A comparison of degenerations in cerebral cortex and brainstem. Adv Neurol. 1974;5:175-193.